Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder. (Q53325164)

13 May 2018

title

Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder. (English)

1 reference

13 May 2018

1 reference

1 reference

6

Rodolfo Montironi

1 reference

13 May 2018

10

Liang Cheng

1 reference

13 May 2018

Antonio Lopez-Beltran

4

object named as

Antonio Lopez-Beltran

1 reference

13 May 2018

author name string

Phillip H Abbosh

1

1 reference

13 May 2018

Mingsheng Wang

2

1 reference

13 May 2018

John N Eble

3

1 reference

13 May 2018

Gregory T Maclennan

5

1 reference

13 May 2018

Suqin Zheng

7

1 reference

13 May 2018

Chong-Xian Pan

8

1 reference

13 May 2018

Honghong Zhou

9

1 reference

13 May 2018

publication date

11 January 2008

1 reference

13 May 2018

published in

Modern Pathology

1 reference

13 May 2018

volume

21

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

355-362

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.3801012

exact match

0 references

cites work

Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

DNA alkylation by the haloethylnitrosoureas: nature of modifications produced and their enzymatic repair or removal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

The fundamental role of epigenetic events in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Gene silencing in cancer in association with promoter hypermethylation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

The role of chromatin during transcription

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

The power and the promise of DNA methylation markers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Molecular genetic evidence supporting the neoplastic nature of stromal cells in 'fibrosis' after chemotherapy for testicular germ cell tumours

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

DNA methylation and cancer therapy: new developments and expectations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

MethyLight: a high-throughput assay to measure DNA methylation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23)

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Control of microtubule stability by the RASSF1A tumor suppressor

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Durable control of small cell carcinoma of the urinary bladder by gemcitabine and paclitaxel

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Frequent hypermethylation of promoter region ofRASSF1A in tumor tissues and voided urine of urinary bladder cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Molecular evidence supporting field effect in urothelial carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Natural history of urothelial dysplasia of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Flat intraepithelial lesions of the urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3801012

7 January 2021

10.1038/MODPATHOL.3801012

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018